Clinical Development, Drug Research and Licensing

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Clinical Development

Drug Research

Licensing

Why Proactive AME Studies are Critical to Accelerating Your Approval Journey

Conversations in Drug Development Trends

FEBRUARY 21, 2024

During clinical development, new chemical entities (NCEs) require an absorption, metabolism, and excretion (AME) study. As a result, we ensure collection of all urine and fecal samples over a period ranging between five to seven days, modifying the participant diet if needed.

Clinical Trials

Clinical Trials Pharmacy Clinical Pharmacology FDA

Using clinical genomics and AI in drug development to elevate success

Drug Target Review

FEBRUARY 11, 2025

Addressing the long timelines and high costs of drug development is therefore critical for the advancement of medical innovation. Unfortunately, many drug candidates fail. Clinical development failure may be due to an inability to demonstrate efficacy or sufficient safety. Unfortunately, many drug candidates fail.

Drug Development

Drug Development Bioinformatics Small Molecule Drugs

Drug Discovery Digest

Why Proactive AME Studies are Critical to Accelerating Your Approval Journey

Using clinical genomics and AI in drug development to elevate success

Stay Connected